GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Ngl Fine Chem NGLFINE.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

2,934.80

+3.62%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹5.01bn

FY2017FY2026

Net income

₹481.3m

FY2017FY2026

Free cash flow

−₹503.1m

FY2017FY2026

Shareholders' equity

₹3.29bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹5.01bn₹3.68bn₹3.39bn₹2.78bn₹3.18bn₹2.58bn₹1.49bn₹1.51bn₹1.11bn₹1.00bn
Research and development—₹50.2m₹47.4m₹24.3m₹17.4m₹18.7m₹37.6m₹14.2m₹7.9m₹9.3m
Operating income₹678.4m₹247.6m₹562.3m₹292.0m₹685.1m₹797.9m₹135.2m₹295.0m₹170.0m₹225.3m
Net income₹481.3m₹211.2m₹413.2m₹205.0m₹499.0m₹567.2m₹83.4m₹201.3m₹125.9m₹142.4m
Diluted earnings per share77.9034.1967.3433.1880.7791.8213.4932.4920.3823.32

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹5.45bn₹4.33bn₹3.56bn₹2.87bn₹2.77bn₹2.08bn₹1.54bn₹1.42bn₹1.29bn₹1.01bn
Cash and short-term investments₹443.0m₹655.3m₹553.1m₹525.0m₹295.5m₹338.5m₹145.5m₹132.1m₹110.5m₹70.5m
Total liabilities₹2.16bn₹1.51bn₹929.0m₹645.3m₹737.1m₹533.1m₹546.6m₹500.7m₹572.5m₹427.4m
Debt₹1.09bn₹731.5m₹340.0m₹325.0m₹300.0m₹164.5m₹282.3m₹271.6m₹266.7m₹203.9m
Shareholders' equity₹3.29bn₹2.82bn₹2.63bn₹2.23bn₹2.03bn₹1.54bn₹989.6m₹921.2m₹720.4m₹585.1m
Shares outstanding6m6m6m6m6m6m6m6m6m6m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹395.4m₹358.2m₹204.7m₹352.9m₹138.2m₹273.5m₹204.6m₹88.5m₹223.6m₹98.3m
Capital spending−₹898.5m−₹1.31bn−₹285.2m−₹314.1m−₹563.8m−₹172.1m−₹149.2m−₹145.0m−₹238.6m−₹180.5m
Free cash flow−₹503.1m−₹949.5m−₹80.6m₹38.8m−₹425.5m₹101.4m₹55.5m−₹56.5m−₹15.0m−₹82.2m
Dividends paid−₹10.8m−₹10.8m−₹10.8m−₹10.8m−₹10.8m−₹10.8m−₹10.8m———

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹1.39bn₹1.49bn₹1.28bn₹1.20bn₹1.04bn₹949.7m₹891.0m₹934.8m
Operating income₹180.3m₹163.6m₹171.3m₹120.7m₹67.1m₹329.2m₹20.0m₹85.3m
Net income₹184.0m₹134.9m₹156.9m₹96.3m₹92.4m₹5.4m₹12.8m₹98.1m
Diluted earnings per share29.7821.8325.4015.5814.960.882.0815.99
Cash from operations———₹167.0m————
Capital spending———−₹250.0m————
Free cash flow———−₹83.0m————
Total assets—₹5.45bn—₹4.84bn—₹4.33bn—₹3.96bn
Cash and short-term investments₹443.0m₹443.0m₹558.9m₹637.3m₹655.3m₹655.3m₹989.9m₹989.9m
Debt—₹1.09bn—₹882.0m—₹731.5m—₹492.0m
Shareholders' equity₹3.29bn₹3.29bn₹3.00bn₹3.00bn₹2.82bn₹2.82bn₹2.80bn₹2.80bn

Financial ratios

Data as of 1 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin13.5%6.7%16.6%10.5%21.6%30.9%—
Net margin9.6%5.7%12.2%7.4%15.7%22.0%—
Return on equity14.6%7.5%15.7%9.2%24.6%36.7%—
Return on assets8.8%4.9%11.6%7.1%18.0%27.3%—
Free cash flow yield7.2%9.3%2.8%3.7%3.9%2.5%—
Revenue growth36.0%8.7%21.8%-12.4%23.1%73.2%—
Earnings growth127.8%-48.9%101.6%-58.9%-12.0%580.5%—
Current ratio1.84x1.98x2.46x2.79x2.64x2.98x—
Debt to equity0.33x0.26x0.13x0.15x0.15x0.11x—
Equity ratio60.4%65.2%73.9%77.5%73.4%74.3%—
Interest coverage15.18x10.61x31.07x15.92x35.81x36.21x—
R&D as a share of sales—1.4%1.4%0.9%0.5%0.7%2.5%
Buybacks as a share of market value0.0%-0.7%0.7%0.0%-0.0%-0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue21.7%14.2%17.9%
Operating income32.4%-3.2%13.7%
Net income32.9%-3.2%15.5%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin10.7%12.0%15.8%16.0%
Net margin8.0%8.8%11.5%11.4%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Price to earnings36.241.126.967.219.0
Price to sales3.52.43.35.03.0

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 12 Aug 2025.

FY2026FY2025FY2024
Paid in the year1.751.751.75

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.